[Second Reprint]

SENATE, No. 3393

STATE OF NEW JERSEY

220th LEGISLATURE

 

INTRODUCED DECEMBER 15, 2022

 


 

Sponsored by:

Senator  M. TERESA RUIZ

District 29 (Essex)

Senator  DECLAN J. O'SCANLON, JR.

District 13 (Monmouth)

 

Co-Sponsored by:

Senators Cruz-Perez, Burgess and Pou

 

 

 

 

SYNOPSIS

     Establishes menstrual health public awareness campaign.

 

CURRENT VERSION OF TEXT

     As reported by the Senate Budget and Appropriations Committee on March 16, 2023, with amendments.

  


An Act establishing a public awareness campaign on menstrual disorders and 1[maternal health,] menstruation-related health conditions and1 supplementing Title 26 of the Revised Statutes 1[, and making an appropriation]1 .

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    The Legislature finds and declares that:

     a.     Menstrual disorders such as endometriosis and polycystic ovarian syndrome affect many women and can have a negative effect on fertility and overall maternal health;

     b.    According to the United States Department of Health and Human Services’ Office on Women’s Health, endometriosis may affect more than 11 percent of American women between the ages of 15 and 44, which is approximately 6.5 million women in the United States alone 2; endometriosis may also occur in pre-menarcheal and post-menopausal individuals2 ;

     c.     According to the Mayo Clinic, endometriosis is an often painful disorder in which tissue similar to the tissue that normally lines the inside of a woman’s uterus, called the endometrium, grows outside the uterus;

     d.    In patients who have endometriosis, the endometrial-like tissue thickens, breaks down, and bleeds 2[with each menstrual cycle]2 . However, since this tissue has no way to exit the body, it becomes trapped;

     e.     When endometriosis impacts the ovaries, cysts called endometriomas may form.  Surrounding tissue can become irritated, eventually developing scar tissue and adhesions that can cause pelvic tissues and organs to stick to each other;

     f.     The primary symptom of endometriosis is pelvic pain.  1[While] Although1 many women experience cramping during their menstrual periods, those with endometriosis typically describe menstrual pain that is much worse than 1[typical and] normal cramping,1 which 1pain1 may increase over time;

     g.    Symptoms of endometriosis include: painful periods 1[(called dysmenorrhea),] known as dysmenorrhea,1 pain with intercourse 1[;] ,1 pain with bowel movements or urination 1[;] ,1 excessive bleeding 1[;] ,1 infertility 1[;] ,1 fatigue 1[;] ,1 diarrhea 1[;] ,1 constipation 1[;] ,1 bloating 1[;] ,1 and nausea;

     h.    Ovarian cancer 1[occurs at higher than expected rates] is more common1 in those who have endometriosis 1as compared with the general population1 ;

     i.     Although rare, another type of cancer called endometriosis-associated adenocarcinoma can develop later in life in those who have had endometriosis;

     j.     According to the 1federal1 Centers for Disease Control and Prevention, polycystic ovary syndrome (PCOS) is one of the most common causes of female infertility, affecting as many as five million, or six to 12 percent, of women of reproductive age in the United States;

     k.    1[This life-long] Polycystic ovary syndrome is a lifelong1 health condition 1[continues] that can affect the lives of people who have it1 far beyond 1their1 child-bearing years and involves other serious health complications;

     l.     Women with PCOS are often insulin resistant, which means that their bodies can make insulin but are unable to use it effectively, increasing their risk for Type 2 diabetes;

     m.   Women with PCOS also have higher levels of androgens, 1which are1 hormones 1[which] that1 can stop eggs from being released and cause irregular periods, acne, thinning scalp hair, and excess hair growth on the face and body;

     n.    More than half of women with PCOS develop type 2 diabetes by age 40.  Women with PCOS can also develop gestational diabetes when pregnant, which puts the pregnancy and baby at risk and can lead to type 2 diabetes later in life for both mother and child;

     o.    Women with PCOS are at higher risk of heart disease, 1[and this] which1 risk increases with age;

     p.    Women with PCOS can also experience: (1) high blood pressure, which can damage the heart, brain, and kidneys; (2) high LDL 1[(bad)] or “bad”1 cholesterol and low HDL 1[(good)] or “good”1 cholesterol, which increases the risk for heart disease; (3) sleep 1[apneaexternal icon] apnea1 , 1which is1 a disorder that causes breathing to stop during sleep and raises the risk for heart disease and type 2 diabetes; and (4) stroke;

     q.    PCOS is also linked to depression and anxiety; 1[and]1

     r.     1Menstrual toxic shock syndrome is a menstruation-related condition that can lead to serious adverse health symptoms, including death if left untreated.  The symptoms of menstrual toxic shock syndrome generally begin with low fever, muscle aches, chills, fatigue, and headaches, but as the condition progresses, symptoms can include high fever, vomiting, rashes, redness of the eyes, lips, and tongue, low blood pressure, and mental confusion;

     s.     Menstrual toxic shock syndrome is generally treatable with antibiotics, but treatment relies on identifying the signs of the condition and seeking professional help.  Anyone can contract menstrual toxic shock syndrome, but women using tampons and similar devices are at a higher risk; and

     t.1  Given all of the increased health risks associated with menstrual disorders, such as endometriosis and PCOS, 1as well as the risks of menstrual toxic shock syndrome,1 and the number of women impacted by these 1[disorders] conditions1 , it is imperative that the Department of Health establish a public awareness campaign about the effects of menstrual disorders 1and menstruation-related conditions1 on fertility and overall maternal health.

 

     2.    a.  The Department of Health shall establish a public awareness campaign to promote awareness among State residents about how menstrual 2and menstruation-related2 disorders 1and menstruation-related conditions1 affect fertility and overall maternal health.  The campaign may provide for the development of print and electronic media in languages including, but not limited to, English and Spanish.

     b.    The public awareness campaign shall include, but not be limited to, the following:

     (1)   a comprehensive description of common menstrual 2and menstruation-related2 disorders, such as endometriosis and PCOS, including discussion of causes, symptoms, and treatment options;

     (2)   1information on the causes and symptoms of menstrual toxic shock syndrome and the ways in which women may reduce the risk of developing the syndrome;

     (3)1  information about educational resources available to women concerning menstrual disorders 2, menstruation-related disorders,2 1and menstruation-related conditions1 ; and

     1[(3)] (4)1  materials encouraging women to schedule routine gynecological examinations 1[and] ,1 consult with their physicians about menstrual 2and menstruation-related2 disorders 1, and seek treatment if they are experiencing symptoms associated with menstrual toxic shock syndrome1 .

     c.     The department shall make available to the public, electronically on its website, information about common menstrual 2and menstruation-related2 disorders, such as endometriosis and PCOS, and their effects on maternal health 1, as well as informational literature concerning the signs, causes, and dangers of menstrual toxic shock syndrome1 .

 

     1[3.  There is appropriated from the General Fund $500,000 to the Department of Health to establish the public awareness campaign pursuant to section 2 of this act.]1

 

     1[4.] 3.1  The Department of Health shall, in accordance with the “Administrative Procedure Act,” P.L.1968, c.410 (C.52:14B-1 et seq.), adopt any rules and regulations as the department deems necessary to implement the provisions of this act.

 

     1[5.] 4.1  This act shall take effect on the 30th day following enactment, except that the Commissioner of Health may take such anticipatory action in advance as shall be necessary for its implementation.